Raymond Debbane - 03 Jun 2026 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Reporting relationship: Director
Issuer ticker: LXRX
Reported as of: 03 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 16:09:59 UTC
Prior SEC filing: 04 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Raymond Debbane

Key filing fact

Raymond Debbane filed Form 4 for LEXICON PHARMACEUTICALS, INC. (LXRX) on 04 Jun 2026.

Key facts

This page summarizes Raymond Debbane's Form 4 filing for LEXICON PHARMACEUTICALS, INC. (LXRX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2026, 16:09.

Change

Previous filing in this sequence was filed on 04 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001053890 Primary reporting owner

DEBBANE RAYMOND

Relationship: Director
Address: 2445 TECHNOLOGY FOREST BLVD., 11TH FLOOR, THE WOODLANDS
Signature: /s/ Raymond Debbane
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LXRX transaction

Common Stock

Options Exercise

Transaction value
Shares: +89,312
Change %: +4.7%
Price: $0.000000^*
Shares after: 1,995,498
Date: 03 Jun 2026
Ownership: Direct

LXRX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,538,462
Date: 03 Jun 2026
Ownership: By Avicenna Life Sci Master Fund LP and related parties

LXRX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,362,368
Date: 03 Jun 2026
Ownership: By Invus Public Equities, L.P. and related parties

LXRX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,451,204
Date: 03 Jun 2026
Ownership: By Invus US Partners, LLC and related parties

LXRX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 35,402,689
Date: 03 Jun 2026
Ownership: By Invus, L.P. and related parties

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LXRX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -89,312
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 03 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 89,312
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of common stock.